Logo image of ATMCR

ALPHATIME ACQUISITION-RIGHT (ATMCR) Stock Price, Quote, News and Overview

NASDAQ:ATMCR - Nasdaq - KYG0223V1398 - Currency: USD

0.1951  0 (-0.2%)

Fundamental Rating

0

Overall ATMCR gets a fundamental rating of 0 out of 10. We evaluated ATMCR against 0 industry peers in the Unkown industry. Both the profitability and financial health of ATMCR have multiple concerns. ATMCR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ATMCR had positive earnings in the past year.
ATMCR had a negative operating cash flow in the past year.
ATMCR Yearly Net Income VS EBIT VS OCF VS FCFATMCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M -1M

1.2 Ratios

Industry RankSector Rank
ROA 2.74%
ROE 3.04%
ROIC N/A
ROA(3y)0.11%
ROA(5y)N/A
ROE(3y)-19.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATMCR Yearly ROA, ROE, ROICATMCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -10 -20 -30 -40 -50

1.3 Margins

ATMCR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATMCR Yearly Profit, Operating, Gross MarginsATMCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ATMCR has more shares outstanding
ATMCR has a worse debt/assets ratio than last year.
ATMCR Yearly Shares OutstandingATMCR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
ATMCR Yearly Total Debt VS Total AssetsATMCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M

2.2 Solvency

ATMCR has an Altman-Z score of -0.15. This is a bad value and indicates that ATMCR is not financially healthy and even has some risk of bankruptcy.
ATMCR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -0.15
ROIC/WACCN/A
WACCN/A
ATMCR Yearly LT Debt VS Equity VS FCFATMCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

ATMCR has a Current Ratio of 0.01. This is a bad value and indicates that ATMCR is not financially healthy enough and could expect problems in meeting its short term obligations.
ATMCR has a Quick Ratio of 0.01. This is a bad value and indicates that ATMCR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
ATMCR Yearly Current Assets VS Current LiabilitesATMCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

ATMCR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.32%.
EPS 1Y (TTM)7.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATMCR Yearly Revenue VS EstimatesATMCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
ATMCR Yearly EPS VS EstimatesATMCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ATMCR is valuated cheaply with a Price/Earnings ratio of 0.98.
ATMCR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
Industry RankSector Rank
PE 0.98
Fwd PE N/A
ATMCR Price Earnings VS Forward Price EarningsATMCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATMCR Per share dataATMCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ATMCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHATIME ACQUISITION-RIGHT

NASDAQ:ATMCR (3/7/2025, 8:06:03 PM)

0.1951

0 (-0.2%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners56.74%
Inst Owner Change26.15%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.34M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.98
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.03
P/tB 0.03
EV/EBITDA N/A
EPS(TTM)0.2
EY102.51%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS7
TBVpS7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.74%
ROE 3.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.11%
ROA(5y)N/A
ROE(3y)-19.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -0.15
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-248.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A